Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 13:10.1021/jacs.4c18304.
doi: 10.1021/jacs.4c18304. Online ahead of print.

Development of a Thioetherification of Heteroarene Electrophiles with Broad Scope via a Proton Transfer Dual Ionization Mechanism

Affiliations

Development of a Thioetherification of Heteroarene Electrophiles with Broad Scope via a Proton Transfer Dual Ionization Mechanism

Christian R Zwick 3rd et al. J Am Chem Soc. .

Abstract

Sulfur-derived functional groups represent prevalent motifs in highly sought-after small molecules, such as active pharmaceutical ingredients (APIs). Thioethers are one such example, being commonly encountered in APIs, prodrugs, and as valuable synthetic "linchpins" to access an array of sulfur-derived functional groups. While nucleophilic aromatic substitution (SNAr) has traditionally been used to synthesize aryl thioethers, modern approaches leverage transition metals to catalyze thermal or photochemical cross-coupling. While studying photochemical thioetherification reactions, we uncovered a remarkably mild condition that does not require light, transition metals, or exogenous bases. An array of thiols and halogenated heterocycles were coupled to produce >70 diverse products. Reaction progress kinetic analysis (RPKA) and computational studies support a unique mechanism termed proton transfer dual ionization (PTDI) SNAr. Finally, a predictive statistical model was constructed aided by high-throughput experimentation (HTE) to understand when the PTDI processes are successful, resulting in the completion of ten target-oriented syntheses. This transformation complements modern approaches to thioether synthesis and motivates additional research evaluating PTDI as a general activation mode between reaction partners.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1.
Scheme 1.
(A) Sulfur-Containing Active Pharmaceutical Ingredients. (B) Synthetic Approaches to Aryl Thioethers. (C) Photocatalyst-Free C–S Coupling Reported by Miyake and Co-Workers. (D) Work Accomplished in this Study
Scheme 2.
Scheme 2.
Proposed Reaction Mechanism Supported by RPKA and Computational Studies
Scheme 3.
Scheme 3.. Nucleophile and Electrophile Substrate Scoped
aGeneral conditions: N (1.1 equiv), E (1.0 equiv), MeCN (0.5M), 18h. bDimerization: thioacetic acid (2.0 equiv), MeCN (0.5M). cThiolation: thioacetic acid (0.5M); Left column: Nucleophile scope; Right column: Electrophile scope; Inset: Competition experiments between E8 and E5. dPPTS = Pyridinium p-Toluene Sulfonate.
Scheme 4.
Scheme 4.. General Data-Driven Workflow for Modeling in This Worka
aThe data set of nucleophiles and electrophiles integrates both initial data and HTE data. Quantum chemical calculations are performed to parametrize the molecules included in the data set. Subsequently, a decision tree classification model is trained based on these parameters. The final decision tree, along with its accuracy and the parameters defining the decision nodes, is visualized. For validation, known targets (target-oriented synthesis) are predicted and tested experimentally.
Scheme 5.
Scheme 5.. Fourteen Targets Used to Validate the Classification Modela
aPTDI: PTDI SNAr conditions used to prepare target; Lit: conditions from literature used to prepare target; Blue square: disconnection prediction in azathioprine. Gray inset: legend for classification model; B = both nucleophile and electrophile out of model; E = electrophile out of model; N = nucleophile out of model; Green inset: PTDI SNAr heterodimerization formal synthesis of TNO-155.

References

    1. Feng M; Tang B; Liang SH; Jiang X Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry. Curr. Top. Med. Chem. 2016, 16, 1200–1216. - PMC - PubMed
    2. Kazemi M; Sajjadifar S; Aydi A; Heydari MM Biological and Pharmaceutical Organosulfur Molecules. J. Med. Chem. Sci. 2018, 1, 1–4.
    3. Ilardi EA; Vitaku E; Njardarson JT Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and Discovery. J. Med. Chem. 2014, 57, 2832–2842. - PubMed
    4. Beno BR; Yeung K-S; Bartberger MD; Pennington LD; Meanwell NA A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design. J. Med. Chem. 2015, 58, 4383–4438. - PubMed
    5. Brown DG; Boström J Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? J. Med. Chem. 2016, 59, 4443–4458. - PubMed
    6. Surur AS; Schulig L; Link A; Surur AS; Schulig L; Link A Interconnection of sulfides and sulfoxides in medicinal chemistry. Arch. Pharm. 2019, 352, No. 1800248. - PubMed
    7. Pei Z; Chen S; Ding L; Liu J; Cui X; Li F; Qiu FJ Nanodrug Delivery Systems in Antitumor Immunotherapy. J. Controlled Release 2022, 352, 211–241. - PubMed
    8. Goundry WRF; Adams B; Benson H; Demeritt J; McKown S; Mulholland K; Robertson A; Siedlecki P; Tomlin P; Vare K Development and Scale-up of a Biocatalytic Process to Form a Chiral Sulfoxide. Org. Process Res. Dev. 2017, 21, 107–113.
    9. Zhou S; Xin Y; Wang J; Wu C; Sun T Application of Continuous Flow in Tazobactam Synthesis. Org. Process Res. Dev. 2021, 25, 1648–1657.
    10. Nishiguchi S; Izumi T; Kouno T; Sukegawa J; Ilies L; Nakamura E Synthesis of Esomeprazole and Related Proton Pump Inhibitors through Iron-Catalyzed Enantioselective Sulfoxidation. ACS Catal. 2018, 8, 9738–9743.
    1. Bunnett JF; Zahler RE Aromatic Nucleophilic Substitution Reactions. Chem. Rev. 1951, 49, 273–412.
    2. Joule JA; Mills K In Heterocyclic Chemistry, 5th ed.; Wiley: Chichester, 2010; p 25.
    3. Cherng Y-J Synthesis of substituted pyridines by the reactions of halopyridines with sulfur, oxygen and carbon nucleophiles under focused microwave irradiation. Tetrahedron 2002, 58, 4931–4935.
    4. Eichman CC; Stambuli JP Transition Metal Catalyzed Synthesis of Aryl Sulfides. Molecules 2011, 16, 590–608. - PMC - PubMed
    5. Liu B; Lim C-H; Miyake GM Transition-Metal-Free, Visible-LightPromoted C–S Cross-Coupling through Intermolecular Charge Transfer. Synlett 2018, 29, 2449–2455. - PMC - PubMed
    6. Liu B; Lim C-H; Miyake GM Visible-Light-Promoted C–S Cross-Coupling via Intermolecular Charge Transfer. J. Am. Chem. Soc. 2017, 139, 13616–13619. - PMC - PubMed
    7. Ishihara Y; Montero A; Baran PS In The Portable Chemist’s Consultant: A Survival Guide for Discovery, Process, and Radiolabeling; Scripps Research Institute: La Jolla, 2016.
    8. Hopkins BA; Zavesky B; White D Thioetherification of Aryl Halides with Thioacetates. J. Org. Chem. 2022, 87, 7547–7550. - PubMed
    9. Saikia RA; Hazarika N; Biswakarma N; Deka RC; Thakur A Metal-free Sarylation of 5-mercaptotetrazoles and 2-mercaptopyridine with unsymmetrical diaryliodonium salts. J. Org. Biomol. Chem. 2022, 20, 3890–3896. - PubMed
    10. Kozlowski MC On the Topic of Substrate Scope. Org. Lett. 2022, 24, 7247–7249. - PubMed
    11. Liu Y-J; Xu H; Kong W-J; Shang M; Dai H-X; Yu J-Q Overcoming the limitations of directed C–H functionalizations of heterocycles. Nature 2014, 515, 389–393. - PMC - PubMed
    1. Moschetta EG; Richter SM; Wittenberger S Heuristics, Protocol, and Considerations for Flow Chemistry in Photoredox Catalysis. ChemPhotoChem 2017, 1, 539–543.
    2. Harper KC; Moschetta EG; Bordawekar SV; Wittenberger S A Laser Driven Flow Chemistry Platform for Scaling Photochemical Reactions with Visible Light. ACS Cent. Sci. 2019, 5, 109–115. - PMC - PubMed
    3. Harper KC; Zhang E-X; Liu Z-Q; Grieme T; Towne TB; Mack DJ; Griffin J; Zheng S-Y; Zhang N-N; Gangula S; Yuan J-L; Miller R; Huang P-Z; Gage J; Diwan M; Ku Y-Y Commercial-Scale Visible Light Trifluoromethylation of 2-Chlorothiophenol Using CF3I Gas. Org. Process Res. Dev. 2022, 26, 404–412.
    4. Dombrowski AW; Gesmundo NJ; Aguirre AL; Sarris KA; Young JM; Bogdan AR; Martin MC; Gedeon S; Wang Y Expanding the Medicinal Chemist Toolbox: Comparing Seven C(sp2)–C(sp3) Cross-Coupling Methods by Library Synthesis. ACS Med. Chem. Lett. 2020, 11, 597–604. - PMC - PubMed
    5. Borlinghaus N; Schönfeld B; Heitz S; Klee J; Vukelic S; Braje WM; Jolit A Enabling Metallophotoredox Catalysis in Parallel Solution-Phase Synthesis Using Disintegrating Reagent Tablets. J. Org. Chem. 2021, 86, 16535–16547. - PubMed
    6. Swift EC; Shekhar S; Kotecki B Synthesis of Enantioenriched β-Aryl-β-aryloxy Esters via Sequential Photoisomerization and Enantioselective Hydrogenation. Org. Lett. 2020, 22, 5363–5368. - PubMed
    1. Newman-Stonebraker SH; Smith SR; Borowski JE; Peters E; Gensch T; Johnson HC; Sigman MS; Doyle AG Univariate Classification of Phosphine Ligation State and Reactivity in Cross-Coupling Catalysis. Science 2021, 374, 301–308. - PubMed
    2. Samha MH; Karas LJ; Vogt DB; Odogwu EC; Elward J; Crawford JM; Steves JE; Sigman MS Redox-Active Ligand Control in C–H Activation: A Model for Selectivity in Cross-Coupling Reactions. Sci. Adv. 2024, 10, No. eadn3478. - PMC - PubMed
    1. Wang Y; Haight I; Gupta R; Vasudevan A What is in Our Kit? An Analysis of Building Blocks Used in Medicinal Chemistry Parallel Libraries. J. Med. Chem. 2021, 64, 17115–17122. - PubMed
    2. Dombrowski AW; Aguirre AL; Shrestha A; Sarris KA; Wang Y The Chosen Few: Parallel Library Reaction Methodologies for Drug Discovery. J. Org. Chem. 2022, 87, 1880–1897. - PubMed

LinkOut - more resources